The frequency of CD20+ T cells is increased in the blood, enriched in the CSF of patients with RRMS, are highly reactive to myelin antigens, are great producers of IFNγ, TNFα and GM-CSF, and are likely involved in the nervous tissue damage observed in MS (14, 16, 40). Here, CSF2 is linked to myeloid sarcoma.